Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1Neoplasms, Second Primary 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Acneiform Eruptions 1

Interventions

Pleurodesis 4Cisplatin 3Chest Tubes 3Bevacizumab 3Silver Nitrate 2Povidone-Iodine 2camrelizumab 1Thoracoscopy 1Thiostrepton 1Sodium Chloride 1Saline Solution 1Radiation 1One-Lung Ventilation 1Morphine 1Magnetic Resonance Spectroscopy 1Lidocaine 1Immunotherapy, Adoptive 1Ibuprofen 1Genes, fms 1Fentanyl 1Drug Therapy 1Doxycycline 1Anesthesia, Local 1Anesthesia, General 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pleural Effusion, Malignant × Doxycycline × Clear all
NCT01411202 2020-09-25

OPUS

Ottawa Hospital Research Institute

Phase 2 Unknown
40 enrolled
Thoracic

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡